Skip to main content
Clinical Trials/ITMCTR2100004282
ITMCTR2100004282RecruitingPhase 1

Clinical Evaluation of Traditional Chinese Medicine-Jiawei Taohong Siwu Decoction in Treating Severe Non-proliferative DRP

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
20 to 80 (—)
Sex
All

Inclusion Criteria

  • (1) All cases were diagnosed as type 2 diabetes patients by the Department of Endocrinology. Women of childbearing age undergo HCG testing.
  • (2) There is no restriction on gender, and the age range is 20 to 70 years old.
  • (3) The changes in the fundus accord with the international clinical classification of DRP as mild, moderate and severe non-proliferative DRP (without DME).
  • (4) The TCM syndrome type belongs to the type of deficiency of both qi and yin and blood stasis blocking the collaterals.

Exclusion Criteria

  • (1) Hyperglycemia is not effectively controlled (fasting blood glucose >= 19.0mmol/L).
  • (2) Cases of other ophthalmological diseases that affect vision or effect observation, such as glaucoma, uveitis, severe cataract, vitreous hemorrhage, fundus vein occlusion, optic neuritis, retinal detachment, etc.
  • (3) Patients with serious diseases such as other organs (such as heart, brain, liver), or mental illness.
  • (4) Diabetic nephropathy and renal failure (uremia stage).
  • (5) Women who are pregnant, preparing to become pregnant or breastfeeding.
  • (6) Observers who do not cooperate and interrupt treatment.

Investigators

Sponsor
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Similar Trials

Clinical Evaluation of Traditional Chinese... | Clinical Trial